Join our expert panel as they discuss the role of Janus kinase (JAK) inhibitors in the treatment of axial spondyloarthritis (axSpA).
Credit available for this activity expires: 4/24/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000707?ecd=bdc_podcast_libsyn_mscpedu
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More